September 24, 2018

Announcing Transition for the Role of Chief Operating Office of HCATS

After three years of operations leadership for Hitachi Chemical Advanced Therapeutics Solutions (HCATS), William (Bill) Monteith will be leaving HCATS with transition expected to complete by November 2018.

Brian Hanifin will fill the role of Interim Head of Technical Operations for HCATS. Brian has 25+ years of extensive pharmaceutical experience leading internal company plants. He has been an independent consultant under HaniPharm, LLC since February 2018. Prior to that he held roles of increasing responsibility at Novartis over more than 22 years leading internal plant and contract manufacturing organizations management. See Brian’s full biography here.

With Brian’s leadership, we fully expect that our Technical Operations for HCATS will continue uninterrupted during this transition.

Brian Hanifin resize (smaller size)

Media Contact Info:

*This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, fomerly PCT or PCT Cell Therapy Services), apceth Biopharma GmbH, and Hitachi Chemical Co., Ltd. have been renamed Minaris Regenerative Medicine and are part of the Resonac Group.

Stay up to date
on the latest news